Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis

Authors

Michael A. Paley, Washington University School of Medicine in St. Louis
Fahad Edrees, Washington University School of Medicine in St. Louis
Satoru Kudose, Washington University School of Medicine in St. Louis
Joseph P. Gaut, Washington University School of Medicine in St. Louis
Prabha Ranganathan, Washington University School of Medicine in St. Louis
Anitha Vijayan, Washington University School of Medicine in St. Louis

Journal

Saudi Journal of Kidney Diseases and Transplantation

Publication Date

2019

Volume

30

Issue

1

Inclusive Pages

226-230

Document Type

Open Access Publication

Rights and Permissions

Paley MA, Edrees F, Kudose S, Gaut JP, Ranganathan P, Vijayan A. Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis. Saudi J Kidney Dis Transpl 2019;30:226-30 Available from: http://www.sjkdt.org/text.asp?2019/30/1/226/252915

Recommended Citation

Paley, Michael A.; Edrees, Fahad; Kudose, Satoru; Gaut, Joseph P.; Ranganathan, Prabha; and Vijayan, Anitha, "Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis." Saudi Journal of Kidney Diseases and Transplantation. 30, 1. 226-230. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7535